SCHEMBL2370615

SCHEMBL2370615

NC[C@H]1CCN([C@@H]2Cc3ccccc3[C@H]2Oc2ccc(Cl)cc2-c2cc[nH]n2)C1

nearest known ligand 0.42

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ TRPC6 Q9Y210 2/20 0.42
▸ TRPC3 Q13507 1/20 0.42
▸ TRPC7 Q9HCX4 1/20 0.42
▸ SLC9A3 P48764 17/20 0.41
▸ CYP2D6 P10635 7/20 0.39
▸ HTR2C P28335 1/20 0.33
▸ HTR2B P41595 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12290640 1.00 TRPC6 (0.42) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL12363442 0.90 TRPC6 (0.39) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL12290647 0.90 SLC9A3 (0.39) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL2369760 0.90 SLC9A3 (0.39) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL2411084 0.90 TRPC6 (0.39) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL2412817 0.86 TRPC6 (0.59) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL2412812 0.86 TRPC6 (0.59) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL12363449 0.85 SLC9A3 (0.39) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL12291258 0.84 TRPC6 (0.49) TRPC6TRPC3TRPC7SLC9A3CYP2D6
SCHEMBL12290638 0.84 TRPC6 (0.49) TRPC6TRPC3TRPC7SLC9A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130131034-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-05-23 — — US claimed
EP-2542524-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-01-09 — — EP claimed
WO-2011107474-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI-AVENTIS (FR) 2011-09-09 — — WO claimed
US-20130131034-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-05-23 — — US disclosed
US-20130131034-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-05-23 — — US disclosed
US-20130131034-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-05-23 — — US disclosed
EP-2542524-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI (FR) 2013-01-09 — — EP disclosed
EP-2368876-A1 Derivatives of aminoindanes, their preparation and their application in therapeutics SANOFI (FR) 2011-09-28 — — EP disclosed
EP-2368876-A1 Derivatives of aminoindanes, their preparation and their application in therapeutics SANOFI (FR) 2011-09-28 — — EP disclosed
WO-2011107474-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI-AVENTIS (FR) 2011-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131034-A1 DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS ANXA2, ANXA3, ADM2 TRPC6 3080/4885TRPC3 2333/4885TRPC7 3887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback